Mankind Pharma Ltd.

NSE: MANKIND | BSE: 543904 | ISIN: INE634S01028 | Industry: Pharmaceuticals
| Expensive Performer
2193.0000 -0.30 (-0.01%)
NSE Dec 26, 2025 15:31 PM
Volume: 254.9K
 

2193.00
-0.01%
Motilal Oswal
MANKIND has a strategic roadmap for growth through expansion in high entry barrier innovative product launches in the chronic/consumer segment and other adjacencies, transitioning from sexual wellness to consumer wellness in the over-the counter (OTC) space.
Number of FII/FPI investors decreased from 648 to 627 in Sep 2025 qtr
More from Mankind Pharma Ltd.
Recommended